Morgan Stanley cut shares of Henry Schein (NASDAQ:HSIC) from an equal weight rating to an underweight rating in a research note issued to investors on Wednesday, Marketbeat reports. Morgan Stanley currently has $88.00 price target on the stock.

Several other research firms have also commented on HSIC. Zacks Investment Research lowered shares of Henry Schein from a buy rating to a hold rating in a report on Wednesday, August 9th. UBS reissued a buy rating on shares of Henry Schein in a research report on Friday, September 15th. Piper Jaffray Companies raised shares of Henry Schein from a neutral rating to an overweight rating in a research report on Friday, September 15th. Jefferies Group reissued a hold rating and set a $89.00 price target on shares of Henry Schein in a research report on Friday, October 20th. Finally, Credit Suisse Group reissued a hold rating and set a $87.50 price target on shares of Henry Schein in a research report on Tuesday, August 29th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company. The stock currently has an average rating of Hold and an average target price of $87.79.

Henry Schein (NASDAQ:HSIC) traded up $0.33 during mid-day trading on Wednesday, hitting $67.90. 2,060,000 shares of the company traded hands, compared to its average volume of 3,010,000. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. Henry Schein has a 52 week low of $65.28 and a 52 week high of $93.50. The company has a market cap of $10,660.00, a price-to-earnings ratio of 18.96, a P/E/G ratio of 1.90 and a beta of 0.99.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Monday, November 6th. The company reported $0.87 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The business had revenue of $3.16 billion for the quarter, compared to the consensus estimate of $3.05 billion. During the same period in the prior year, the business posted $0.84 EPS. Henry Schein’s revenue for the quarter was up 10.3% on a year-over-year basis. equities analysts predict that Henry Schein will post 3.6 earnings per share for the current fiscal year.

Henry Schein announced that its Board of Directors has authorized a stock buyback plan on Monday, September 18th that permits the company to buyback $400.00 million in shares. This buyback authorization permits the company to buy up to 6.3% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

In other news, Director Barry J. Alperin sold 5,796 shares of the firm’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $70.76, for a total value of $410,124.96. Following the completion of the sale, the director now directly owns 48,172 shares of the company’s stock, valued at approximately $3,408,650.72. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 1.19% of the company’s stock.

Several large investors have recently bought and sold shares of HSIC. Alecta Pensionsforsakring Omsesidigt lifted its position in shares of Henry Schein by 112.0% in the 3rd quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock worth $435,693,000 after purchasing an additional 2,806,990 shares during the period. Mackenzie Financial Corp lifted its position in shares of Henry Schein by 106.0% in the 3rd quarter. Mackenzie Financial Corp now owns 3,938,233 shares of the company’s stock worth $322,896,000 after purchasing an additional 2,026,867 shares during the period. Janus Henderson Group PLC lifted its position in shares of Henry Schein by 92.1% in the 3rd quarter. Janus Henderson Group PLC now owns 2,814,636 shares of the company’s stock worth $230,777,000 after purchasing an additional 1,349,333 shares during the period. Atlanta Capital Management Co. L L C lifted its position in shares of Henry Schein by 99.4% in the 3rd quarter. Atlanta Capital Management Co. L L C now owns 2,493,054 shares of the company’s stock worth $204,405,000 after purchasing an additional 1,242,849 shares during the period. Finally, Neuberger Berman Group LLC lifted its position in shares of Henry Schein by 95.9% in the 3rd quarter. Neuberger Berman Group LLC now owns 2,475,058 shares of the company’s stock worth $202,930,000 after purchasing an additional 1,211,743 shares during the period. 91.75% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Henry Schein (HSIC) Downgraded by Morgan Stanley” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.dailypolitical.com/2017/12/09/henry-schein-hsic-downgraded-by-morgan-stanley.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.